Health Economics

The National Institute for Value and Technology in Healthcare (NIHO) has officially rejected the request to broaden the use of Dapagliflozin (Forxiga) for adult...

A groundbreaking diagnostic tool, LIAISON MeMed BV (LMMBV), is set to revolutionize the treatment of community-acquired pneumonia (CAP) in Canada by accurately distinguishing between...

Thailand is set to enhance its tuberculosis (TB) diagnostic approach by integrating the Xpert MTB/RIF assay as the primary testing method. This decision stems...

A recent comprehensive study highlights the varying effectiveness of lifestyle modification programs aimed at improving health behaviors among adults with learning disabilities, indicating a...

Hospitals are witnessing a significant uptick in musculoskeletal injuries among children and adolescents, highlighting urgent financial and medical challenges. A recent study spanning 2021...

Health technology assessments (HTAs) often overlook the quality of life impacts on informal carers, especially those caring for children with rare, progressive, life-limiting conditions....

Health economists have determined that annual influenza vaccinations and COVID-19 booster shots provide significant economic benefits, particularly among high-risk populations. Recent analyses indicate these...

A recent study has demonstrated that integrating penpulimab with standard chemotherapy significantly enhances the cost-effectiveness of treatment for patients battling metastatic squamous non-small cell...

Since initiating a pilot program in 2012, China's effort to reform public hospitals at the county level has sparked varied responses regarding its effectiveness....

Medical expenses continue to strain the financial stability of Iranian families, revealing critical socio-economic and demographic challenges. A recent study utilizing data from nearly...

A recent study explores the effectiveness of AI-supported ultrasound scans conducted by nurses without ultrasound training in diagnosing deep vein thrombosis (DVT). The research...

A recent economic analysis reveals that introducing the drug nivolumab combined with chemotherapy can significantly reduce treatment costs for non-small cell lung carcinoma (NSCLC)...

Tuberculosis (TB) control in the United States heavily relies on outbreak investigations, yet their full impact and financial viability were previously unclear. A recent...

England's latest analysis reveals significant variations in the cost-effectiveness of COVID-19 vaccines across different age and risk groups. As the nation transitions to managing...

The General Directorate of Pharmacy under the Ministry of Health has launched a detailed framework aimed at assessing the effectiveness of pharmaceuticals. Initiated in...